Ra Capital Management, L.P. Celldex Therapeutics, Inc. Transaction History

Ra Capital Management, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$34.78 - $47.43 $11.8 Million - $16.1 Million	-340,028 Reduced 16.39%	1,734,972 $62.4 Million
Q1 2022 May 16, 2022	BUY	$27.64 - $39.32 $7.47 Million - $10.6 Million	270,205 Added 14.97%	2,075,000 $70.7 Million
Q4 2021 Feb 14, 2022	BUY	$35.68 - $56.27 $7.31 Million - $11.5 Million	204,795 Added 12.8%	1,804,795 $69.7 Million
Q3 2021 Nov 15, 2021	BUY	$28.95 - $55.99 $46.3 Million - $89.6 Million	1,600,000 New	1,600,000 $86.4 Million
Q4 2020 Feb 16, 2021	SELL	$14.99 - $22.75 $5.29 Million - $8.03 Million	-353,072 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$9.65 - $15.19 $7.69 Million - $12.1 Million	-796,928 Reduced 69.3%	353,072 $5.24 Million
Q2 2020 Aug 14, 2020	BUY	$1.61 - $13.41 $1.85 Million - $15.4 Million	1,150,000 New	1,150,000 $15 Million

206

70.2M

1.46M

868K

Ticker CLDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,772,400
Market Cap $1.06B
Description
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.